NorthSea Therapeutics: NorthSea Therapeutics B.V.: NorthSea Therapeutics Receives FDA Rare Pediatric Disease Designation for SEFA-6179 for the Treatment of Intestinal Failure-Associated Liver Disease

RPD designation underscores critical need for novel therapies to address IFALD NorthSea Therapeutics B.V. (NST), a biotech company developing novel and innovative strategies for the treatment of n...